Olson, R., Mathews, L., Liu, M., Schellenberg, D., Mou, B., Berrang, T., . . . Gaede, S. (2020). Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): Study protocol for a randomized phase III trial. BMC Cancer, 20(1), 1. https://doi.org/10.1186/s12885-020-06876-4
Chicago Style (17th ed.) CitationOlson, Robert, et al. "Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of 1-3 Oligometastatic Tumors (SABR-COMET-3): Study Protocol for a Randomized Phase III Trial." BMC Cancer 20, no. 1 (2020): 1. https://doi.org/10.1186/s12885-020-06876-4.
MLA (9th ed.) CitationOlson, Robert, et al. "Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of 1-3 Oligometastatic Tumors (SABR-COMET-3): Study Protocol for a Randomized Phase III Trial." BMC Cancer, vol. 20, no. 1, 2020, p. 1, https://doi.org/10.1186/s12885-020-06876-4.